TRACON Pharmaceuticals, Inc. Gains 18.49%
Thu, Sep 10, 2020 at 05:30 PM
TRACON Pharmaceuticals, Inc. (TCON:NASDAQ) shot up at $4.23, a gain of 18.5%. On Wed 09 Sep 20, TCON:NASDAQ hit a New 2-Week Intraday High of $4.05. The stock appeared on our News Catalysts scanner on Thu 10 Sep 20 at 08:46 AM in the 'MISCELLANEOUS' category. From Wed 26 Aug 20, the stock recorded 88.89% Up Days and 80.00% Green Days
About TRACON Pharmaceuticals, Inc. (TCON:NASDAQ)
TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.
Top 10 Gainers:
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 53.79%
- Renren Inc. (RENN:NYSE), 40%
- Pingtan Marine Enterprise Ltd. (PME:NASDAQ), 32.36%
- Novan, Inc. (NOVN:NASDAQ), 27.23%
- QH (QH:NASDAQ), 24.55%
- Virtusa Corporation (VRTU:NASDAQ), 24.49%
- Agenus Inc. (AGEN:NASDAQ), 23.87%
- Paratek Pharmaceuticals, Inc. (PRTK:NASDAQ), 21.08%
- Rhodium (RH:NYSE), 20.05%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 18.49%